Common Contracts
2 similar Asset Sale and Purchase Agreement contracts by Angiotech Pharmaceuticals Inc
Confidential Portions Ommitted) ASSET SALE AND PURCHASE AGREEMENT BY AND AMONG ANGIOTECH PHARMACEUTICALS, INC., SURGICAL SPECIALTIES PUERTO RICO, INC., QUILL MEDICAL, INC., ETHICON, INC. and ETHICON, LLC DATED AS OF APRIL 4, 2012Asset Sale and Purchase Agreement • November 13th, 2012 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • New York
This ASSET SALE AND PURCHASE AGREEMENT (the “Agreement”) is entered into as of April 4, 2012, by and among Angiotech Pharmaceuticals, Inc., a corporation formed under the Laws of British Columbia with offices at 1618 Station Street, Vancouver, BC, Canada V6A 1B6 (the “Company”), Surgical Specialties Puerto Rico, Inc., a Puerto Rico corporation with offices at RD 459 KM 0.6, Montana Industrial Park, Aguadilla, Puerto Rico (“Subsidiary 1”) and Quill Medical, Inc., a Delaware corporation with offices at 1633 Westlake Avenue North, Suite 400, Seattle, WA 98109-6227 (“Subsidiary 2”, and collectively, with the Company and Subsidiary 1, “Seller”, each of them is severally referred to as a “Seller Party”), Ethicon, Inc., a New Jersey corporation with offices at Route 22 West, P.O. Box 151, Somerville, NJ 08876 (“Buyer 1)”) and Ethicon, LLC, a Delaware limited liability company with offices at 475 Calle C Suite 401, Los Frailes Industrial Park, Guaynabo, PR 00969 (“Buyer 2” and collectively, wi
Confidential Portions Ommitted) ASSET SALE AND PURCHASE AGREEMENT BY AND AMONG ANGIOTECH PHARMACEUTICALS, INC., SURGICAL SPECIALTIES PUERTO RICO, INC., QUILL MEDICAL, INC., ETHICON, INC. and ETHICON, LLC DATED AS OF APRIL 4, 2012Asset Sale and Purchase Agreement • August 14th, 2012 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • New York
This ASSET SALE AND PURCHASE AGREEMENT (the “Agreement”) is entered into as of April 4, 2012, by and among Angiotech Pharmaceuticals, Inc., a corporation formed under the Laws of British Columbia with offices at 1618 Station Street, Vancouver, BC, Canada V6A 1B6 (the “Company”), Surgical Specialties Puerto Rico, Inc., a Puerto Rico corporation with offices at RD 459 KM 0.6, Montana Industrial Park, Aguadilla, Puerto Rico (“Subsidiary 1”) and Quill Medical, Inc., a Delaware corporation with offices at 1633 Westlake Avenue North, Suite 400, Seattle, WA 98109-6227 (“Subsidiary 2”, and collectively, with the Company and Subsidiary 1, “Seller”, each of them is severally referred to as a “Seller Party”), Ethicon, Inc., a New Jersey corporation with offices at Route 22 West, P.O. Box 151, Somerville, NJ 08876 (“Buyer 1)”) and Ethicon, LLC, a Delaware limited liability company with offices at 475 Calle C Suite 401, Los Frailes Industrial Park, Guaynabo, PR 00969 (“Buyer 2” and collectively, wi
